Stocks and Investing Stocks and Investing
Tue, September 20, 2016
[ 07:46 AM ] - WOPRAI
EnteroMedics Inc. (NASDAQ:ETRM), Up After BUYINS. .. uld Go Up Due To Conditions Outlined In Our Repor
[ 07:46 AM ] - WOPRAI
Halozyme Therapeutics Inc. (NASDAQ:HALO), Up By $ .. T SqueezeTrigger Report Released on Monday, Septe
[ 07:46 AM ] - WOPRAI
Aegerion Pharmaceuticals Inc. (NASDAQ:AEGR), Up A .. cted Stock Would Go Up Due To Conditions Outlined
[ 07:45 AM ] - WOPRAI
DTS Inc. (NASDAQ:DTSI), Up After BUYINS.NET Repor .. ld Go Up Due To Conditions Outlined In Our Report
[ 07:45 AM ] - WOPRAI
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD), Up Aft .. d Stock Would Go Up Due To Conditions Outlined In
[ 07:45 AM ] - WOPRAI
Corcept Therapeutics Incorporated (NASDAQ:CORT), .. edicted Stock Would Go Up Due To Conditions Outli
[ 07:45 AM ] - WOPRAI
Digirad Corporation (NASDAQ:DRAD), Up After BUYIN .. Would Go Up Due To Conditions Outlined In Our Rep
[ 07:45 AM ] - WOPRAI
LTS SqueezeTrigger Price is $2.25. There is $10,753,758 That Short Sellers Still Need To Cover.
[ 07:45 AM ] - WOPRAI
CAT SqueezeTrigger Price is $82.43. There is $3,2 .. 1,549,904 That Short Sellers Still Need To Cover.
[ 01:46 AM ] - WOPRAI
PYS, IEZ, XES, IPHS, GLUU, UYG Are Seasonally Ripe To Go Down In the Next Five Weeks
[ 01:46 AM ] - WOPRAI
NPO, STV, XRM, LINC, IBIO, SODA Are Seasonally Ripe To Go Down In the Next Five Weeks
[ 01:45 AM ] - WOPRAI
FTI, LECO, CNQ, HOS, IXC, ACTG Are Seasonally Ripe To Go Down In the Next Five Weeks
[ 01:45 AM ] - WOPRAI
STO, XLE, IGE, OSTK, IYE, XEC Are Seasonally Ripe To Go Down In the Next Five Weeks
[ 01:45 AM ] - WOPRAI
CLNE, UDOW, CDXS, RRTS, IVR, SMI Are Seasonally Ripe To Go Down In the Next Five Weeks
[ 01:45 AM ] - WOPRAI
AGZ, CLW, DDG, CHIQ, FXY, AAT Are Seasonally Ripe To Go Up In the Next Five Weeks
[ 12:45 AM ] - WOPRAI
STJ Expected To Be Down Before Next Earnings Releases
[ 12:00 AM ] - WOPRAI
Stacy Rasgon Upgraded (AMD) to Hold on, Sep 20th, 2016
[ 12:00 AM ] - WOPRAI
Christopher Rolland Initiated (AMD) at Hold and Held Target at $6.5 on, Sep 20th, 2016
[ 12:00 AM ] - WOPRAI
William Katz Maintained (BEN) at Hold with Decreased Target to $39 on, Sep 20th, 2016
[ 12:00 AM ] - WOPRAI
Mark Delaney Upgraded (APH) to Strong Buy and Increased Target to $18 on, Sep 20th, 2016
[ 12:00 AM ] - WOPRAI
Ken Zerbe Downgraded (CBSH) to Sell on, Sep 20th, 2016
[ 12:00 AM ] - WOPRAI
Jay McCanless Initiated (CCS) at Buy and Held Target at $20 on, Sep 20th, 2016
[ 12:00 AM ] - WOPRAI
Jay McCanless Initiated (TPH) at Buy and Held Target at $17 on, Sep 20th, 2016
[ 12:00 AM ] - WOPRAI
Brian Nagel Initiated (WSM) at Buy on, Sep 20th, 2016
[ 12:00 AM ] - WOPRAI
Betsy Graseck Upgraded (WFC) to Buy and Decreased Target to $53 on, Sep 20th, 2016
[ 12:00 AM ] - WOPRAI
John Eade Initiated (VOD) at Hold on, Sep 20th, 2016
[ 12:00 AM ] - WOPRAI
Eric Stine Initiated (ASPN) at Strong Buy on, Sep 20th, 2016
[ 12:00 AM ] - WOPRAI
Matthew Sheerin Downgraded (AVT) to Hold on, Sep 20th, 2016
[ 12:00 AM ] - WOPRAI
Christopher Rolland Initiated (AVGO) at Buy on, Sep 20th, 2016
[ 12:00 AM ] - WOPRAI
Andrew Baum Maintained (BMY) at Strong Buy with Decreased Target to $70 on, Sep 20th, 2016

Andrew Baum Maintained (BMY) at Strong Buy with Decreased Target to $70 on, Sep 20th, 2016


Published on 2024-10-25 18:33:24 - WOPRAI, Andrew Baum
  Print publication without navigation


Andrew Baum of Citigroup, Maintained "Bristol-Myers Squibb Company" (BMY) at Strong Buy with Decreased Target from $75 to $70 on, Sep 20th, 2016.

Andrew has made no other calls on BMY in the last 4 months.



There are 3 other peers that have a rating on BMY. Out of the 3 peers that are also analyzing BMY, all agree with Andrew's Rating of Hold. Following are those relevant analyst calls for the last 4 months

  • Jeffrey Holford of "Jefferies" Maintained at Hold with Decreased Target to $57 on, Monday, September 12th, 2016
  • Gregg Gilbert of "Deutsche Bank" Maintained at Hold with Decreased Target to $62 on, Monday, August 8th, 2016
  • Vamil Divan of "Credit Suisse" Downgraded from Buy to Hold and Decreased Target to $63 on, Sunday, August 7th, 2016
Contributing Sources